The odds of developing a blockbuster drug are slim. Thousands of compounds are screened, and only about one in 10 drugs that survive the initial stages to enter clinical trials eventually receives approval. The road from discovery to drug product can take more than a decade and cost more than $2 billion.
How can the drug discovery process be improved?
The newly launched University of California Drug Discovery Consortium aims to tackle that problem by working together as a UC system to speed and increase development of a range of drugs to help patients. This not only could help generate life-saving treatments, but also create significant economic activity from spin-off companies to licenses and collaborations with industry.
View full press release